Pfizer stock slips 1.39% in mixed trading session

7 articles · Updated · MarketWatch · May 1

Shares closed at $26.33 as the S&P 500 rose 0.29% to 7,230.12 and the Dow Jones fell 0.31% to 49,499.27.
Pfizer underperformed Eli Lilly, whose shares gained 3.07%, while Johnson & Johnson fell 1.16% and Abbott Laboratories dropped 1.46%.
The stock finished 8.40% below its 52-week high of $28.75, reached on 2 April.

With Pfizer’s dividend payout now exceeding earnings, could a dividend cut be looming despite management’s reassurances?

Can Pfizer’s heavy pipeline investments and AI adoption reverse its sliding fortunes, or is the company headed for a prolonged decline?

As Eli Lilly surges ahead in obesity drugs, does Pfizer’s late entry and reliance on acquisitions signal deeper innovation challenges?